Letter: Unblocking of T lymphocytes

Resistance of Transgenic Prunus domestica to Plum Pox Virus Infection.

Plant disease·2019

Prunus Host Range of Plum pox virus (PPV) in the United States by Aphid and Graft Inoculation.

Plant disease·2019

Field Trials of Plum Clones Transformed with the Plum pox virus Coat Protein (PPV-CP) Gene.

Plant disease·2019

Histamine release positive test associates with disease remission in chronic spontaneous urticaria: a proof-of-concept study.

European annals of allergy and clinical immunology·2017

Patients with breakthrough reactions to iodinated contrast media have low incidence of positive skin tests.

European annals of allergy and clinical immunology·2016

IgG4-related disease in Italy: clinical features and outcomes of a large cohort of patients.

Scandinavian journal of rheumatology·2015

[177Lu]Lu-PSMA-617 in patients with PSMA-positive metastatic androgen pathway modulator-naive/sensitive prostate cancer (PSMAddition): a phase 3 randomised, controlled trial.

Lancet (London, England)·2026

Multivessel coronary artery bypass grafting via small thoracotomy versus sternotomy (MIST): an investigator-initiated, international, open-label, randomised controlled trial.

Lancet (London, England)·2026

Efficacy and safety of once-weekly subcutaneous zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in type 2 diabetes: a multicentre, randomised, parallel, double-blind, placebo-controlled, dose-finding, phase 2 trial.

Lancet (London, England)·2026

Efficacy and safety of once-daily oral zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in adults with type 2 diabetes: a multicentre, randomised, parallel, double-blind, placebo-controlled, dose-finding, phase 2 trial.

Lancet (London, England)·2026

Quizartinib Resistance Mutations and Treatment Outcomes in Relapsed or Refractory FLT3-ITD-Positive AML.

Cancer science·2026

Receptor-tethered orthogonal IL-2 enhances regulatory T cell therapy.

The Journal of experimental medicine·2026

Electrochemiluminescence immunoassay for quantifying ZMA001 in human serum: method development, validation, and clinical pharmacokinetic application.

Bioanalysis·2026

Surgery compared with medical treatment in patients with type A aortic intramural hematoma: a systematic review and meta-analysis.

Journal of thoracic disease·2026

Molecular mechanisms of bacteria-mediated cancer immunotherapy: from intratumoral microbiota to engineered therapeutics.

Frontiers in immunology·2026

Risk stratification for immune checkpoint inhibitor rechallenge after acute kidney injury: towards a precision medicine framework.

Frontiers in immunology·2026

Related Experiment Videos

Letter: Unblocking of T lymphocytes

Related Concept Videos

Resistance of Transgenic Prunus domestica to Plum Pox Virus Infection.

Prunus Host Range of Plum pox virus (PPV) in the United States by Aphid and Graft Inoculation.

Field Trials of Plum Clones Transformed with the Plum pox virus Coat Protein (PPV-CP) Gene.

Histamine release positive test associates with disease remission in chronic spontaneous urticaria: a proof-of-concept study.

Patients with breakthrough reactions to iodinated contrast media have low incidence of positive skin tests.

IgG4-related disease in Italy: clinical features and outcomes of a large cohort of patients.

[177Lu]Lu-PSMA-617 in patients with PSMA-positive metastatic androgen pathway modulator-naive/sensitive prostate cancer (PSMAddition): a phase 3 randomised, controlled trial.

Multivessel coronary artery bypass grafting via small thoracotomy versus sternotomy (MIST): an investigator-initiated, international, open-label, randomised controlled trial.

Efficacy and safety of once-weekly subcutaneous zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in type 2 diabetes: a multicentre, randomised, parallel, double-blind, placebo-controlled, dose-finding, phase 2 trial.

Efficacy and safety of once-daily oral zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in adults with type 2 diabetes: a multicentre, randomised, parallel, double-blind, placebo-controlled, dose-finding, phase 2 trial.

Quizartinib Resistance Mutations and Treatment Outcomes in Relapsed or Refractory FLT3-ITD-Positive AML.

Receptor-tethered orthogonal IL-2 enhances regulatory T cell therapy.

Electrochemiluminescence immunoassay for quantifying ZMA001 in human serum: method development, validation, and clinical pharmacokinetic application.

Surgery compared with medical treatment in patients with type A aortic intramural hematoma: a systematic review and meta-analysis.

Molecular mechanisms of bacteria-mediated cancer immunotherapy: from intratumoral microbiota to engineered therapeutics.

Risk stratification for immune checkpoint inhibitor rechallenge after acute kidney injury: towards a precision medicine framework.

Related Experiment Videos

Letter: Unblocking of T lymphocytes

Related Concept Videos

Related Articles